Lipoprotein (a) LIPOA

Synonyms
Allscripts (AEHR) Order Name	Lipoprotein A, Serum
Sunrise Clinical Manager (SCM) Order Name	Lipoprotein A, Serum
EPIC Order Name	Lipoprotein (a)
Clinical Info	Lp(a) is an independent prospective risk factor for coronary heart disease. Lp(a) determination is intended for use in conjunction with clinical evaluation, patient risk assessment, and other lipid tests to evaluate disorders of lipid metabolism and to assess coronary heart disease in specific populations.
Specimen Type	Blood
Specimen Volume	1 mL of serum ( 0.5 mL min)
Container	Gold Top Tube
Collection Instructions	Separate serum from cells as soon as possible (within two hours).
Transport Instructions	Refrigerate
Specimen Stability	5 days at 15-25 °C 20 days at 2-8 °C 13 weeks frozen at -20 °C (± 5 °C)
Methodology	Immunoturbidimetric
Days Performed	Monday to Sunday
Performing Laboratories	Northwell Health Core Lab (CFAM)
CPT	83695
PDM	5904270
Result Interpretation < 75 nmol/L = Low Lp(a) attributable ASCVD risk 75 nmol/L to 125 nmol/L = Intermediate Lp(a) attributable ASCVD risk >= 125 nmol/L = High Lp(a) attributable ASCVD risk, with increasing risk with higher Lp(a) values Elevated Lp(a) is an important risk factor for atherosclerotic CVD and calcific aortic valve disease. Lp(a) levels represent a continuum of risk, not a risk threshold at a dichotomous cutpoint. Reference: National Lipid Association (NLA) scientific statement on use of lipoprotein(a) in clinical practice (Journal of Clinical Lipidology, 2024; 18, e308-e319)
Forms

edit